What is the address of E.G. Klinische Biologie?

The registered office of E.G. Klinische Biologie is located at Louis Van Houttestraat 74, 9050 Gent.

Is E.G. Klinische Biologie still active?

Yes. According to the CBE (3 November 2026) E.G. Klinische Biologie is active, legal situation “Normale toestand”, started on 23 July 2025.

Is E.G. Klinische Biologie registered on Peppol?

Yes, E.G. Klinische Biologie is registered on the Peppol network with ID 0208:1025799843.

What is the enterprise number of E.G. Klinische Biologie?

The enterprise number of E.G. Klinische Biologie is BE1025799843.

When was E.G. Klinische Biologie founded?

E.G. Klinische Biologie was founded on 23 July 2025.

Who are the directors of E.G. Klinische Biologie?

According to the 2025 annual accounts, the directors of E.G. Klinische Biologie are: Eva Gijbels.

Is E.G. Klinische Biologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 July 2025; 1 annual account filed (fiscal year 2025); 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did E.G. Klinische Biologie make in 2025?

E.G. Klinische Biologie posted a profit after taxes of € 12,204 in financial year 2025.

What is the revenue of E.G. Klinische Biologie?

As a small company, E.G. Klinische Biologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,090.

E.G. Klinische Biologie (Private Limited) - Gent

Dossier E.G. Klinische Biologie, printed on 3 November 2026 from databakkes.be/en/1025799843/e-g-klinische-biologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

E.G. Klinische Biologie from Gent, company number BE1025799843, closed financial year 2025 with a result of € 12,204 after tax. For that financial year E.G. Klinische Biologie recorded a gross margin of € 19,090 and equity of € 12,345. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 12,345

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,204

Profit after tax over the fiscal year.

Cash in the bank

€ 4,156

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 859 paid out

7 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 394 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 394

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,085

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,919

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

What happened to E.G. Klinische Biologie?

What happened at E.G. Klinische Biologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 12,204. Source: NBB ↗
Jul 25, 2025 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jul 23, 2025 New establishment in Nazareth-De Pinte. KBO
2025 Eva Gijbels became a director. NBB

In short

Paid € 4,661 in corporate taxes since 2025.

Paid out € 859 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Eva Gijbels

E.G. Klinische Biologie

Behind E.G. Klinische Biologie is Eva Gijbels.

Directors

According to the 2025 annual accounts

Eva Gijbels

Director

since 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Louis Van Houttestraat 74

9050 Gent

2.377.000.143

Oudstrijderslaan 4

9840 Nazareth-De Pinte

Active since 23 July 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

25 July 2025 Source: Deed ↗

GIJBELS Eva(oprichter) 100%

Details

Company number: 1025.799.843
VAT number: BE 1025.799.843
Registered office: Louis Van Houttestraat 74, 9050 Gent
Names & denominations: E.G. Klinische Biologie · EGKB
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 July 2025
Peppol: Active · Active since 20 Aug 2025

View on CBE Public ↗ Annual accounts (NBB) ↗